Additional file 1: of Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort

Additional file 2: of An attempt at modeling COPD epidemiological trends in France

Pierre-RĂŠgis Burgel (5461883)
Caroline Laurendeau (5461880)
Chantal Raherison (59830)
Claire Fuhrman (5461877)
Nicolas Roche (113352)

June 2018

2A: COPD prevalence by age, gender, and GOLD stage in the 2005 French general population. 2B: Preval...

Additional file 4: Table S3. of Treatment adequacy of anxiety disorders among young adults in Finland

Teija Kasteenpohja (3432578)
Mauri Marttunen (3226587)
Terhi Aalto-Setälä (3432572)
Jonna Perälä (3432569)
Samuli Saarni (3432575)
Jaana Suvisaari (364516)

March 2016

Sociodemographic factors, comorbid disorders, benzodiazepine use and misuse during the most intensiv...

Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension:the case of benzodiazepines

Bijlsma, Maarten J.
Hak, Eelko
Bos, Jens
De Jong-van den Berg, Lolkje T. W.
Janssen, Fanny

September 2013

Purpose The aim of this study was to investigate whether including the birth cohort dimension in tim...

Additional file 2: of Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort

Guillaume Airagnes (5159030)
CĂŠdric Lemogne (6587471)
Adeline Renuy (6701234)
Marcel Goldberg (111570)
Nicolas Hoertel (285091)
Yves Roquelaure (301796)
FrĂŠdĂŠric Limosin (6701237)
Marie Zins (111574)

May 2019

Table S2. Prevalence of benzodiazepine long-term use in women of the French general population in 20...

Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort

Airagnes, Guillaume
Lemogne, Cedric
Renuy, Adeline
Goldberg, Marcel
Hoertel, Nicolas
Roquelaure, Yves
Limosin, Frédéric
Zins, Marie

May 2019

International audienceBACKGROUND:Data are lacking regarding the prevalence of benzodiazepine long-te...

Table_1_The Problem of Benzodiazepine Use and Its Extent in the Driver Population: A Population-Based Registry Study.DOCX

Francisco Herrera-Gómez (5145212)
Eduardo Gutierrez-Abejón (5145218)
Paloma Criado-Espegel (5145215)
F. Javier Álvarez (5145209)

April 2018

<p>Background: Benzodiazepines are driving-impairing medicines (DIM). This study presents current co...

RESEARCH ARTICLE Open Access Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study

Sophia Rosman
Marc Le Vaillant
Nathalie Pelletier-fleury

August 2015

Background: In recent decades, benzodiazepine (BZD) prescriptions have been called into question in ...

Additional file 1 of Work accident effect on the use of psychotropic drugs: the case of benzodiazepines

Thomas Barnay (17273306)
François-Olivier Baudot (17273309)

October 2023

Additional file 1: Table A. Health status differences in the WA and the non-WA groups in 2015. Table...

Data_Sheet_1_Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study.docx

Kristien Coteur (12972584)
Pavlos Mamouris (6856706)
Bert Vaes (3413906)
Marc Van Nuland (12972587)
Catharina Matheï (605402)
Birgitte Schoenmakers (5876366)

September 2022

BackgroundContrary to most European guidelines, benzodiazepine receptor agonists (BZRA) are often us...

Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study.

Rosman, Sophia
Le Vaillant, Marc
Pelletier-Fleury, Nathalie

January 2011

International audienceBACKGROUND: In recent decades, benzodiazepine (BZD) prescriptions have been ca...

Presse Med

BENARD-LARIBIERE, Anne
PARIENTE, Antoine

October 2018

Benzodiazepine use remains high in France in 2015, especially among the elders. However, encouraging...

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project

Huerta, Consuelo
Abbing-Karahagopian, Victoria
Requena, Gema
Oliva, Belén
Alvarez, Yolanda
Gardarsdottir, Helga
Miret, Montserrat
Schneider, Cornelia
Gil, Miguel
Souverein, Patrick C
De Bruin, Marie L
Slattery, Jim
De Groot, Mark C H
Hesse, Ulrik
Rottenkolber, Marietta
Schmiedl, Sven
Montero, Dolores
Bate, Andrew
Ruigomez, Ana
García-Rodríguez, Luis Alberto
Johansson, Saga
de Vries, Frank
Schlienger, Raymond G
Reynolds, Robert F
Klungel, Olaf H
de Abajo, Francisco José
Sub Gen. Pharmacoepi and Clinical Pharm
Sub Clinical Pharmacy, Pharmacoepi
Sub Pharmacoepidemiology
Sub Pharmacotherapy, Theoretical
Pharmacoepidemiology and Clinical Pharmacology

March 2016

PURPOSE: Studies on drug utilization usually do not allow direct cross-national comparisons because ...

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases : A cross-national descriptive study from the PROTECT-EU Project

Huerta, Consuelo
Abbing-Karahagopian, Victoria
Requena, Gema
Oliva, Belén
Alvarez, Yolanda
Gardarsdottir, Helga
Miret, Montserrat
Schneider, Cornelia
Gil, Miguel
Souverein, Patrick C.
De Bruin, Marie L.
Slattery, Jim
de Groot, Mark C H
Hesse, Ulrik
Rottenkolber, Marietta
Schmiedl, Sven
Montero, Dolores
Bate, Andrew
Ruigomez, Ana
García-Rodríguez, Luis Alberto
Johansson, Saga
de Vries, Frank
Schlienger, Raymond G.
Reynolds, Robert F.
Klungel, Olaf H.
de Abajo, Francisco José

January 2016

Purpose: Studies on drug utilization usually do not allow direct cross-national comparisons because ...

Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension: the case of benzodiazepines

Bijlsma, Maarten J.
Hak, Eelko
Bos, Jens
De Jong-van den Berg, Lolkje T. W.
Janssen, Fanny

September 2013

Purpose The aim of this study was to investigate whether including the birth cohort dimension in tim...

Additional file 2: of An attempt at modeling COPD epidemiological trends in France

Pierre-RĂŠgis Burgel (5461883)
Caroline Laurendeau (5461880)
Chantal Raherison (59830)
Claire Fuhrman (5461877)
Nicolas Roche (113352)

June 2018

2A: COPD prevalence by age, gender, and GOLD stage in the 2005 French general population. 2B: Preval...

Additional file 4: Table S3. of Treatment adequacy of anxiety disorders among young adults in Finland

Teija Kasteenpohja (3432578)
Mauri Marttunen (3226587)
Terhi Aalto-Setälä (3432572)
Jonna Perälä (3432569)
Samuli Saarni (3432575)
Jaana Suvisaari (364516)

March 2016

Sociodemographic factors, comorbid disorders, benzodiazepine use and misuse during the most intensiv...

Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension:the case of benzodiazepines

Bijlsma, Maarten J.
Hak, Eelko
Bos, Jens
De Jong-van den Berg, Lolkje T. W.
Janssen, Fanny

September 2013

Purpose The aim of this study was to investigate whether including the birth cohort dimension in tim...

Additional file 2: of Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort

Guillaume Airagnes (5159030)
CĂŠdric Lemogne (6587471)
Adeline Renuy (6701234)
Marcel Goldberg (111570)
Nicolas Hoertel (285091)
Yves Roquelaure (301796)
FrĂŠdĂŠric Limosin (6701237)
Marie Zins (111574)

May 2019

Table S2. Prevalence of benzodiazepine long-term use in women of the French general population in 20...

Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort

Airagnes, Guillaume
Lemogne, Cedric
Renuy, Adeline
Goldberg, Marcel
Hoertel, Nicolas
Roquelaure, Yves
Limosin, Frédéric
Zins, Marie

May 2019

International audienceBACKGROUND:Data are lacking regarding the prevalence of benzodiazepine long-te...

Table_1_The Problem of Benzodiazepine Use and Its Extent in the Driver Population: A Population-Based Registry Study.DOCX

Francisco Herrera-Gómez (5145212)
Eduardo Gutierrez-Abejón (5145218)
Paloma Criado-Espegel (5145215)
F. Javier Álvarez (5145209)

April 2018

<p>Background: Benzodiazepines are driving-impairing medicines (DIM). This study presents current co...

RESEARCH ARTICLE Open Access Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study

Sophia Rosman
Marc Le Vaillant
Nathalie Pelletier-fleury

August 2015

Background: In recent decades, benzodiazepine (BZD) prescriptions have been called into question in ...

Additional file 1 of Work accident effect on the use of psychotropic drugs: the case of benzodiazepines

Thomas Barnay (17273306)
François-Olivier Baudot (17273309)

October 2023

Additional file 1: Table A. Health status differences in the WA and the non-WA groups in 2015. Table...

Data_Sheet_1_Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study.docx

Kristien Coteur (12972584)
Pavlos Mamouris (6856706)
Bert Vaes (3413906)
Marc Van Nuland (12972587)
Catharina Matheï (605402)
Birgitte Schoenmakers (5876366)

September 2022

BackgroundContrary to most European guidelines, benzodiazepine receptor agonists (BZRA) are often us...

Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study.

Rosman, Sophia
Le Vaillant, Marc
Pelletier-Fleury, Nathalie

January 2011

International audienceBACKGROUND: In recent decades, benzodiazepine (BZD) prescriptions have been ca...

Presse Med

BENARD-LARIBIERE, Anne
PARIENTE, Antoine

October 2018

Benzodiazepine use remains high in France in 2015, especially among the elders. However, encouraging...

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project

Huerta, Consuelo
Abbing-Karahagopian, Victoria
Requena, Gema
Oliva, Belén
Alvarez, Yolanda
Gardarsdottir, Helga
Miret, Montserrat
Schneider, Cornelia
Gil, Miguel
Souverein, Patrick C
De Bruin, Marie L
Slattery, Jim
De Groot, Mark C H
Hesse, Ulrik
Rottenkolber, Marietta
Schmiedl, Sven
Montero, Dolores
Bate, Andrew
Ruigomez, Ana
García-Rodríguez, Luis Alberto
Johansson, Saga
de Vries, Frank
Schlienger, Raymond G
Reynolds, Robert F
Klungel, Olaf H
de Abajo, Francisco José
Sub Gen. Pharmacoepi and Clinical Pharm
Sub Clinical Pharmacy, Pharmacoepi
Sub Pharmacoepidemiology
Sub Pharmacotherapy, Theoretical
Pharmacoepidemiology and Clinical Pharmacology

March 2016

PURPOSE: Studies on drug utilization usually do not allow direct cross-national comparisons because ...

Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases : A cross-national descriptive study from the PROTECT-EU Project

Huerta, Consuelo
Abbing-Karahagopian, Victoria
Requena, Gema
Oliva, Belén
Alvarez, Yolanda
Gardarsdottir, Helga
Miret, Montserrat
Schneider, Cornelia
Gil, Miguel
Souverein, Patrick C.
De Bruin, Marie L.
Slattery, Jim
de Groot, Mark C H
Hesse, Ulrik
Rottenkolber, Marietta
Schmiedl, Sven
Montero, Dolores
Bate, Andrew
Ruigomez, Ana
García-Rodríguez, Luis Alberto
Johansson, Saga
de Vries, Frank
Schlienger, Raymond G.
Reynolds, Robert F.
Klungel, Olaf H.
de Abajo, Francisco José

January 2016

Purpose: Studies on drug utilization usually do not allow direct cross-national comparisons because ...

Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension: the case of benzodiazepines

Bijlsma, Maarten J.
Hak, Eelko
Bos, Jens
De Jong-van den Berg, Lolkje T. W.
Janssen, Fanny

September 2013

Purpose The aim of this study was to investigate whether including the birth cohort dimension in tim...

Additional file 2: of An attempt at modeling COPD epidemiological trends in France

Pierre-RĂŠgis Burgel (5461883)
Caroline Laurendeau (5461880)
Chantal Raherison (59830)
Claire Fuhrman (5461877)
Nicolas Roche (113352)

June 2018

2A: COPD prevalence by age, gender, and GOLD stage in the 2005 French general population. 2B: Preval...

Additional file 4: Table S3. of Treatment adequacy of anxiety disorders among young adults in Finland

Teija Kasteenpohja (3432578)
Mauri Marttunen (3226587)
Terhi Aalto-Setälä (3432572)
Jonna Perälä (3432569)
Samuli Saarni (3432575)
Jaana Suvisaari (364516)

March 2016

Sociodemographic factors, comorbid disorders, benzodiazepine use and misuse during the most intensiv...

Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension:the case of benzodiazepines

Bijlsma, Maarten J.
Hak, Eelko
Bos, Jens
De Jong-van den Berg, Lolkje T. W.
Janssen, Fanny

September 2013

Purpose The aim of this study was to investigate whether including the birth cohort dimension in tim...

Additional file 1: of Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort

Abstract

Extracted data

Additional file 1: of Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort

Abstract

Extracted data

Related items

Related items